• Latest Posts
In Depth 11 Feb 2019

CRISPR: One Patent to Rule Them All

Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease

The Patent Office has Spoken: What does it Mean for CRISPR in Europe?

UPDATE: No Clear Winner in the CRISPR Patent Battle

ADVERTISEMENT